19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
A problem faced by the administrators of 401(k) and other retirement plans is what to do about plan ...
Read More >
The state of New York adopted a new section of the New York Labor Law in November 2019. Under the i...
Read More >
The OCC announced yesterday that it’s bringing enforcement actions against five former Wells Fargo ...
Read More >
On June 5, 2019, the Massachusetts Supreme Judicial Court (SJC) issued a decision emphasizing that a...
Read More >
Employers often do not like to pay overtime, although they must, and they sometimes come up with cre...
Read More >
A company that does not perform adequate due diligence prior to a merger or acquisition may face bot...
Read More >